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Prosthetic graft infection (PGI) after surgery to recon-struct the thoracic aorta is a devastating complication.The reported incidence is between 1% and 3%.1 Treat-ment of this complication remains a challenge for sur-
geons, and chances of a successful outcome are considered low.
Mortality rates range from 25% to 75%, and morbidity in surviving
patients is high.2
Most reports advocate a management strategy that combines
removal of all the prosthetic material, removal of surrounding
tissue, and extra-anatomic arterial reconstruction.3-5 However,
such a major surgical undertaking may not be possible in most
cases because of the technically challenging nature of the surgery,
and because most patients usually have multiorgan dysfunction
caused by sepsis, making the procedure risky.
In this report, we define the outcome and management strate-
gies for PGI after surgery to reconstruct the thoracic aorta. We
report our experience of managing PGI with a more conservative
approach.
Clinical Summary
From 1996 to 2005, all the names of patients undergoing prosthetic
graft replacement of the thoracic aorta in a single unit were
prospectively placed in a database. A retrospective review of case
notes was performed.
A diagnosis of PGI was made in patients with signs of sepsis,
namely, pyrexia, leukocytosis, and increased C-reactive protein
coupled with evidence on computed tomography scanning of peri-
graft collection or air.
Results
During the study period, more than 400 consecutive patients under-
went graft replacement of the thoracic aorta. The following proce-
dures were undertaken: aortic arch replacement (38 cases, 9.5%),
composite aortic root replacement (162 cases, 40.5%), and interposi-
tion graft to the ascending aorta plus aortic valve replacement (200
cases, 50%). The mortality for the entire group was 13%.
Eight patients (2%) had PGI. They underwent the following
procedures: aortic arch replacement (2 cases), composite aortic
root replacement (3 cases), and interposition graft to the ascending
aorta plus aortic valve replacement (3 cases). Demographic details
for individual patients are shown in Table 1. The mean age was 63
years (15); 6 were elective cases and 2 were urgent cases.
In 6 patients, PGI was associated with sternal wound sepsis. Of
these 6 patients, 5 with sternal wound involvement underwent
surgical reexploration, extensive debridement of necrotic tissue
within the mediastinum, mediastinal irrigation with dilute Povi-
dine iodine, and sternal reconstruction. All survived. One patient
with sternal wound sepsis was treated conservatively. This patient
underwent an aortic valve replacement and replacement of the
ascending aorta for an intraoperative ascending aortic dissection. A
methicillin-resistant Staphylococcus aureus PGI developed in the
patient, which was complicated by a pseudoaneurysm of the prox-
imal aortic anastomotic suture line. She died 27 days after the
initial surgery.
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TABLE 1. Demographic features of the cohort
Patient Age Sex Euroscore Procedure Priority Redo Circulatory arrest
1 80 M 10 AVR  CABG  composite root replacement Elective No Yes
2 61 M 9 Aortic homograft root replacement Emergency Yes No
3 71 M 10 AVR  CABG  composite root replacement Elective No No
4 34 M 8 AVR  composite root replacement Elective No No
5 70 F 10 Aortic arch replacement Elective No Yes
6 49 M 13 AVR  interposition graft Elective Yes No
7 73 F 10 AVR  interposition graft Elective Yes No
8 66 M 8 Hemiarch replacement Emergency No Yes
AVR, Aortic valve replacement; CABG, coronary artery bypass graft.
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Two patients had infection of aortic graft prosthesis without
sternal wound involvement. One patient had Marfan syndrome and
had originally undergone a composite aortic root replacement with
a mechanical valve conduit. He presented 28 days after surgery
with a Candida albicans PGI. This was complicated by false
aneurysm of the ascending aorta. This patient underwent a suc-
cessful redo aortic root replacement with a composite porcine
xenograft.
The second patient underwent a composite aortic root replacement
plus partial replacement of the aortic arch. She presented weeks after
surgery with C. albicans PGI. It was elected to treat her conserva-
tively with antifungal agents. She died of multiorgan failure second-
ary to mediastinal sepsis 10 weeks after the initial operation.
The median intensive therapy unit stay was 8 days (range 3–74
days). The median survival for the 6 patients discharged from the
hospital was 5.8 years (range 0.25–7 years). There was 1 late death
6 years after the procedure. No patient had recurrence of sepsis
affecting either the wound or the aortic prosthesis (Table 2).
Discussion
PGI after aortic reconstruction represents a difficult problem to
mange. Redo surgery is technically challenging and mortality rates
remain high, up to 42% even with an aggressive surgical strategy.1,2
In this report we showed that the incidence of PGI after surgery
of the thoracic aorta is low (2%) and mostly related to sternal
wound sepsis. When associated with sternal wound sepsis, a lim-
ited surgical strategy involving extensive mediastinal debridement
and mediastinal irrigation resulted in a good outcome in the
majority of cases. Removal of the infective prosthesis was not
required. Cases in which the graft was infected without sternal
wound involvement were unusual. In these cases, removal of the
infected prosthesis and reconstruction of the aorta are recom-
mended. In all cases, the best outcome was achieved with prompt
surgery.
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TABLE 2. Outcome of the cohort
Patient No.
Days from surgery
to infection Pathogen
Sternal wound
involvement Operative procedure
ICU
stay
Hospital
stay Outcome
1 10 Staphylococcus aureus Yes Mediastinal debridement 4 38 Survived
2 6 Enterobacter D species Yes Mediastinal debridement 26 53 Survived
3 8 Coagulase-negative S. aureus Yes Mediastinal debridement 5 23 Survived
4 30 Candida albicans No Redo aortic root replacement 2 11 Survived
5 10 C. albicans No Nonoperative 74 74 Died
6 12 S. aureus Yes Mediastinal debridement 3 8 Survived
7 9 Methicillin-resistant S. aureus Yes Nonoperative 11 27 Died
8 26 Coagulase-negative S. aureus Yes Mediastinal debridement 32 76 Survived
ICU, Intensive care unit.
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